Table 2.
Overview of all patient characteristics.
Tumor subtypes | No. of patients (%) |
---|---|
ER status | |
Positive | 318 (74.7%) |
Negative | 108 (25.4%) |
PR status | |
Positive | 242 (56.8%) |
Negative | 184 (43.2%) |
HER2 immunohistochemistry | |
Positive | 88 (20.7%) |
Negative | 338 (79.3%) |
Triple negative status | |
Positive | 62 (14.6%) |
Negative | 364 (85.4%) |
Blood group | |
A | 198 (46.5%) |
B | 43 (10.1%) |
AB | 22 (5.2%) |
O | 163 (38.3%) |